跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Wosulin-30/70 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Wosulin-30/70
Approved
STANDARD
Wosulin-30/70
Wockhardt Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f2860882002e6285
Company
Wockhardt Ltd.
Type
Standard
Approval Details
Approval Id
f2860882002e6285
Drug Approval Philippines Name
Wosulin-30/70
Product Name
Wosulin-30/70
Registration Number
BRP-054
Brand Name
Wosulin-30/70
Generic Name
Biphasic Isophane Insulin Human (Recombinant DNA Origin)
Dosage Form
Suspension for Injection (SC) (30% Regular Insulin Human/70% Isophane Insulin Human)
Dosage Strength
100IU/mL
Manufacturer
Wockhardt Ltd.
Importer
Ambica International Corp.
Distributor
GX Laboratories, Inc.
Issuance Date
28 January 2019
Expiry Date
10 February 2029
Pharmacologic Category
Intermediate-acting Insulin
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f2860882002e6285
Type
Standard
Back to Philippines FDA Approvals